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tau.ac.il (Y. Shiloh).The DNA of all organisms is constantly subjected to damaging agents, both exogenous and endoge-
nous. One extremely harmful lesion is the double-strand break (DSB), which activates a massive sig-
naling network – the DNA damage response (DDR). The chief activator of the DSB response is the
ATM protein kinase, which phosphorylates numerous key players in its various branches. Recent
phosphoproteomic screens have extended the scope of damage-induced phosphorylations beyond
the direct ATM substrates. We review the evidence for the involvement of numerous other protein
kinases in the DDR, obtained from documentation of speciﬁc pathways as well as high-throughput
screens. The emerging picture of the protein phosphorylation landscape in the DDR broadens the
current view on the role of this protein modiﬁcation in the maintenance of genomic stability. Exten-
sive cross-talk between many of these protein kinases forms an interlaced signaling network that
spans numerous cellular processes. Versatile protein kinases in this network affect pathways that
are different from those they have been identiﬁed with to date. The DDR appears to be one of the
most extensive signaling responses to cellular stimuli.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V.1. The protein kinase core of the DNA damage response
The genomes of all living organisms constantly suffer deleteri-
ous attacks. Of the many types of DNA lesions, one the most harm-
ful is the double-stranded break (DSB). DSBs are caused by
exogenous agents such as ionizing radiation (IR) and radiomimetic
chemicals, or by endogenous agents, mainly reactive oxygen spe-
cies. DSBs are also generated during the normal processes of mei-
otic recombination and V(D)J recombination [1]. Failure to repair
DSBs, or their misrepair, may result in cell death or chromosomal
rearrangements, including deletions and translocations, which in
turn may promote neoplastic transformation. In order to cope with
this lesion, cells activate a complex network of interacting path-
ways that lead either to damage repair and resumption of the nor-
mal cellular life cycle or to programmed cell death. This network,
called the DNA damage response (DDR), coordinates the activation
of cell cycle checkpoints, the appropriate DNA repair pathways,
and numerous other responses [2].al Societies. Published by Elsevier
Molecular Systems Biology,
chschule Zürich, 8093 Zürich,
2 3 6407471 (Y.Shiloh).
. Bensimon), yossih@post.-Timely cellular response to DSBs requires that the DNA damage
signal be conveyed swiftly and precisely to numerous processes
across the cell. The signal transduction mechanism that dissemi-
nates the DNA damage alarm begins with sensor proteins that
sense the damage or chromatin alterations emanating from it
and mediate the activation of transducers, which in turn convey
the alarm to numerous downstream effectors involved in speciﬁc
pathways [2]. The primary transducer of the DSB alarm is the ser-
ine–threonine protein kinase ataxia telangiectasia mutated (ATM),
which phosphorylates numerous key players in the various
branches of the DDR [3,4].
ATM is a member of the phosphoinositide 3-kinase (PI3K)-re-
lated protein kinase (PIKK) family, which also includes ATM and
Rad3-related protein (ATR), the catalytic subunit of DNA-depen-
dent protein kinase (DNA-PKcs), hSMG1, and mammalian target
of rapamycin (mTOR) kinases [5]. DNA-PK is a major player in
the repair of DSBs induced by genotoxic stresses or during V(D)J
recombination, via non-homologous end-joining (NHEJ) [6,7].
ATM and ATR transduce a complex signaling response to various
stimuli, but most prominently to damage to DNA. ATM has been
documented primarily as a critical component of the response to
DSBs, but has recently emerged also in the general response to
reactive oxygen species [8–12]. ATM is largely nuclear, but there
is evidence that a cytoplasmic fraction of ATM is involved inB.V. Open access under CC BY-NC-ND license.
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metabolic processes [9,13–18].
ATR is activated mainly by single-stranded DNA (ssDNA) ends
that are generated following the induction of DNA adducts or dur-
ing the processing of DSBs or collapsed replication forks. Their
length as well as ssDNA–dsDNA junctions are key factors in ATR’s
activation [19–23]. Evidence of ATR being activated by other mech-
anisms independent of ssDNA has also been obtained [24].
ATM and ATR show functional redundancy and share overlap-
ping substrate speciﬁcity; both preferentially phosphorylate serine
or threonine residues that are followed by glutamine (‘‘SQ/TQ’’
motifs) in their substrates [3,4,19,20,24,26]. Matsuoka et al. [27]
identiﬁed more than 700 proteins containing the ATM/ATR phos-
phorylation motif (SQ/TQ) that are inducibly phosphorylated in re-
sponse to IR. We assume that most of these potential substrates
will turn out to be physiological. One reason for this multitude of
substrates is that ATM phosphorylates many targets within each
ATM-dependent pathway, and ﬁne-tunes various processes by
modulating a number of pathways within the same process [28].
A typical example is the DNA damage-induced activation and sta-
bilization of the p53 protein, which ATM modulates by phosphor-
ylation of p53 itself as well as many of its regulators [28–35].
Importantly, some of the ATM/ATR substrates are themselves pro-
tein kinases that target downstream effectors, most notably CHK1
and CHK2 [36–38].
The functional relationship between ATM and ATR in the DSB
response is complex. It is generally assumed that after the rapid
activation of ATM in response to DNA damage and the subsequent
phosphorylation of its numerous substrates, ATR is triggered and
maintains phosphorylation of some of these substrates [28]. Re-
cently, it was shown that the ATM–ATR switch is driven by the
length of ssDNA ends formed as a result of end resection at DSB
sites [21]. In response to UV or replication stress, ATR mediates
downstream activation of ATM [39]. On the other hand, during
the S and G2 phases of the cell cycle, the response of ATR to DSBs
that are not part of the replication process is dependent on ATM
[40,41]. ATM is involved in the activation of ATR, at least by phos-
phorylation of the ATR activator topoisomerase II binding protein 1
(TopBP1) [42]. The downstream target kinases of ATR and ATM,
CHK1 and CHK2, are also activated as a consequence of the
cross-talk between ATM and ATR. Both ATM and ATR are required
for CHK1 activation in response to IR, and both are required for
CHK2 activation in response to UV and replication stress
[39,41,43,44], since CHK2 cannot be activated by ATR alone [45–
47]. CHK1 phosphorylation and subsequent activation in cells is
ATR-dependent, and ATR was recently shown in a reconstituted
system to directly phosphorylate CHK1 [48,49]. ATM can activate
directly CHK2, but the full activation of CHK2 is a multi-step pro-
cess that also requires polo-like kinase 3 (PLK3)-mediated phos-
phorylations, autophosphorylations and CHK2 oligomerization
[46,50,51]. Both CHK1 and CHK2 also antagonize their own activi-
ties via regulatory feedback loops involving phosphatases [52,53],
and both are promoted to dissociate from the chromatin in re-
sponse to DNA damage [54,55]. Less is known about the direct
functional relationships between DNA-PK and the other PIKK fam-
ily members. In response to DSB induction, DNA-PKcs is exten-
sively autophosphorylated [6,7], and undergoes phosphorylation
on Thr2609 and Thr2647 in an ATR-dependent manner in response
to UV but not IR, and in an ATM dependent manner in response
to IR [56,57]. The autophosphorylation of DNA-PK at Ser2056 occurs
at different kinetics according to DNA damage inducer [58].
Notably, cells depleted of ATM exhibit lower levels of IR-induced
phosphorylation of CHK1 and CHK2, of which only CHK1 phos-
phorylation is abrogated completely by the addition of a DNA-PK
inhibitor [59]. In certain cell lines, CHK2 phosphorylation in re-
sponse to IR was impaired in cells with defective DNA-PK, or inthe presence of a DNA-PK inhibitor [60]. These complex relation-
ships among the canonical protein kinases in the DDR exemplify
an intricate level of functional interactions among protein kinases
in all tiers of this network.2. Expanding the kinase landscape
We [61] and Bennetzen et al. [62] recently reported studies
exploring the DNA damage-induced phosphoproteome, and
provided a broader perspective of the signaling dynamics elicited
by radiation [62] or radiomimetic [61] damage. The relatively
small proportion of phosphorylation events that occurred on the
SQ/TQmotifs in these studies attests to the extended scope of dam-
age-induced phosphorylation events that was uncovered. The use
of an ATM inhibitor in our study [61] provided an assessment of
the degree of ATM dependence of cellular protein phosphorylation
response to radiomimetic damage. Although ATM is a major regu-
lator of this response, we identiﬁed a substantial fraction of ATM-
independent events – about 40% of all damage-induced phosphor-
ylation events. Together with the modest proportion of SQ/TQ
phosphorylations suggests that the DDR may involve an extensive
kinase network, beyond ATM. However, it is also possible that
other kinases respond to DNA lesions other than DSBs, while the
DSB response is still largely controlled by ATM. The plethora of
DNA base lesions induced by IR or reactive oxygen species (ROS)
induced by IR in cells is probably a relevant example. Here, we in-
tend to review the published evidence for the involvement of pro-
tein kinases other than ATM/ATR in the DDR, with special attention
to those that are activated or inhibited following DNA damage
induction. Since DSBs are induced by a variety of chemicals as well
as IR, our list will be permissive and include kinases that were acti-
vated by various chemicals. We did, however, exclude kinases
shown to be induced by UV damage only. The ﬁve most prominent
DDR kinases – ATM, ATR, DNA-PK, CHK1 and CHK2 – have been
extensively reviewed recently [3,4,6,19,24–26,36–38,63–67] and
therefore will not be discussed here in detail. The functional inter-
actions between them and the expanding network of substrates,
within and across pathways, are constantly being explored, but
the relationships between them and many of the kinases men-
tioned below remain largely elusive. We categorized these protein
kinases according to cellular processes and kinase families. How-
ever, we believe that the extensive cross-talks between these pro-
teins (Fig. 1) attest to an interlaced signaling network that spans
numerous cellular processes, in which versatile protein kinases
can affect pathways that are beyond the functions and classes with
which they have been identiﬁed to date. In the following text we
will discuss protein kinases with ample information on their
involvement in the DDR, and mention others more brieﬂy in Table
1.
2.1. Cell cycle-regulating protein kinases
A major arm of the DDR activates cell cycle checkpoints, which
temporarily stop cell cycle progression while the damage is as-
sessed and processed [38,68–70]. It is not surprising therefore that
the large number of kinases involved in cell cycle regulation also
respond to DNA damage. This begins with the cyclin-dependent ki-
nases (CDKs) themselves: in response to several DNA damaging
agents, CDK1 and CDK2 phosphorylation at Tyr15 were up-regu-
lated [71–73]. However, in cisplatin-treated H1299 cells, if CDK1
was depleted, CDK2 was not phosphorylated and retained kinase
activity [73]. Depletion of WEE1, the kinase that phosphorylates
CDK1 and CDK2 on Tyr15, led to an activated DDR due to intrinsic
DNA damage as a result of deregulation of CDKs, and was accom-
panied by activation of CHK1 [74,75]. Other DNA damage-induced
Fig. 1. The expanding protein kinase landscape of the DNA damage response. This diagram depicts proteins discussed in the text but not those that were identiﬁed in high-
throughput screens (Table 2). Nodes represent protein kinases (squares), phosphatases (diamonds) and other proteins mentioned in the text (circles). Colors denote pathways
by which kinases were described: blue – DNA damage response; red – cell cycle control; yellow – MAPK pathways; green – Akt, NFkB, mTOR pathways. Nodes sizes are
proportional to the number of edges. Functional cross-talks (dependency, activation, inhibition, or physical interaction) which are mentioned in this text were depicted as
edges between the proteins. The ﬁgure was prepared using Cytoscape [25].
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2. In IR-treated chicken DT40 cells, the activity of CDK2 was en-
hanced through Thr160 phosphorylation in a CHK1-dependent
manner, which played a role in controlling centrosome ampliﬁca-
tion [76]. CDK1 protein and activity levels were reduced in re-
sponse to doxorubicin, in part due to phosphorylation of CDK1 at
Tyr4 by double-stranded RNA (dsRNA)-activated protein kinase
(PKR) [77]. Finally, c-Abl down-regulated the activity of CDK2 in
response to IR, leading to growth arrest [78]. The ATM/CHK2, the
ATR/CHK1, and p38/MK2 pathways converge to control CDK1/2
by inactivation of the CDC25 phosphatases (reviewed in [79]). An-
other mechanism by which ATM controlled CDK1 activity was via
phosphorylation of Artemis, which in turn modulated the forma-
tion of CDK1–cyclin B complex and controlled recovery from the
DNA damage-induced G2 arrest [80]. CDK1 also regulates CHK1
and CHK2: in cells depleted of CDK1, the phosphorylation of
CHK1 on Ser317 following cisplatin treatment was impaired, and
so was the BRCA1-regulated phosphorylation of CHK1 and CHK2
on Ser317 and Thr68, respectively, following IR [73]. Irrespective of
DNA damage, CDK1 phosphorylated CHK1 at Ser286/Ser301 duringmitosis, promoting sequestration of CHK1 to the cytoplasm and en-
abling timely activation of CDK1 itself [81]. This feedback loop is
likely to be modulated in response to DNA damage.
CDK4/6 are inhibited in response to DNA damage, and this is
one of the pathways that lead to the G1/S checkpoint. Similar to
the p53-mediated pathway that contributes to this checkpoint, this
one is ATM-dependent: it relies on ATM-mediated phosphorylation
of the F-box only protein 31 (FBXO31), which mediates the degra-
dation of cyclin D1 [82]. Inhibition of MAPK/ERK kinase (MEK1/2)
also inhibited IR-induced cyclin D1 degradation, likely because of
inhibition of IR-induced extracellular-signal regulated kinase
(ERK) activation [82,83]. ERK can induce cyclin D1 degradation
via F-box/WD repeat containing protein 8 (FBXW8), but depletion
of FBXW8 did not modulate IR-induced cyclin D1 degradation, so it
would seem that the IR-induced activation of MEK/ERK pathway
was involved differently [82]. CDK5 was found to be involved in
the DDR in a high-throughput screen for proteins whose loss is
synthetic lethal with inhibition of poly(ADP-ribose) polymerase
(PARP), together with other kinases, including ATM, ATR, CHK1,
polo-like kinase 3 (PLK3) and p38c. CDK5 depletion demonstrated
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IR [84]. In post-mitotic neurons, CDK5 activity was up-regulated in
response to DNA damage, and it was implicated in ATM activation
by phosphorylating it on Ser794 and in cell cycle re-entry in re-
sponse to DNA damage [85]. Of note, c-Abl can phosphorylate
CDK5 at Tyr15, thereby promoting CDK5 kinase activity [86].
CDK5 activity was considerably up-regulated in response to CPT
in the nuclear compartment to which c-Abl is translocated, sug-
gesting a putative interplay between the two protein kinases in
the DDR [85–87].
Polo-like kinases (PLKs) regulate mitotic entry, spindle pole
checkpoints and cytokinesis [88], and of these PLK1 and PLK3 have
been implicated in the DDR. PLK1 is activated following phosphor-
ylation by Aurora-A on Thr210, which promotes entry into mitosis
[89]. In response to IR and other DNA damaging agents, PLK1’s
activity was inhibited by down-regulation of Thr210 phosphoryla-
tion, which was implicated in cell cycle arrest [90,91]. Depletion
or inhibition of ATM, CHK1 or protein phosphatase 2A (PP2A) abro-
gated PLK1’s response to damage [91–94]. In cells treated with
doxorubicin at G2, PLK1 was degraded, which was required for
the cells to maintain an efﬁcient G2 checkpoint. Degradation was
mediated via the anaphase-promoting complex/cyclosome (APC/
C). Impaired degradation of PLK1 reduced the levels of CHK1 phos-
phorylation on Ser317 and reduced the levels of the WEE1 kinase
[95]. PLK1 phosphorylates CDC25C on Ser198, thereby promoting
nuclear accumulation of the phosphatase, and this phosphoryla-
tion event is likely to be regulated also in the DDR [96]. PLK3
was phosphorylated in response to IR in an ATM-dependent man-
ner [97]. PLK3 phosphorylated CHK2 on Ser62/Ser73, and partici-
pated in CHK2 activation in vivo; these phosphorylation events
primed CHK2 for full activation by ATM [46,97]. Similar to CHK1
and CHK2, PLK3 inactivated CDC25C by phosphorylating it onTable 1
Additional protein kinases implicated in the DDR.
Protein kinase Brief summary
CK1a IR-induced CDC25A degradation is regulated by casei
NEK6 In response to IR, NEK6 was phosphorylated, possibly
BUBR1 BUBR1 +/ cells failed to arrest at the G2/M checkpo
H2AX phosphorylation compared to WT cells
TTK/MPS1 TTK phosphorylated CHK2 on Thr68 and was phospho
maintaining the IR-induced G2/M checkpoint
GRK5 GRK5 promoted inhibition of cisplatin-induced apopt
MK5 MK5 was involved in the regulation of miR34c-modul
response to DNA damage
p21-activated kinase 2
(PAK2/cPAK)
PAK2 kinase activity was up-regulated in response to
UV or cisplatin was wortmannin independent
Tropomyosin related kinase
A (TrkA)
Following CPT treatment, JNK modulated the activati
SY5Y cells, ectopic expression of TrkA increased NHEJ
the NHEJ player XRCC4
Mixed lineage kinase 3
(MLK3)
Silencing of MLK3 resulted in elevated basal NF-jB s
treatment and indicating that MLK3 had an inhibitor
NUAK1 Irrespective of DNA damage, The senescence-regulati
regulated by Akt, and promoted ATM activity, implica
Protein kinase D (PKD) In neuronal cells, PKD was rapidly phosphorylated on
independent manner. It was suggested that the antiox
stimuli, including oxidative stress, by blocking this ph
IKK
IKKe The IKKe kinase was implicated in the DNA damage-in
the nucleus, phosphorylated the PML protein, and was
to the anti-apoptotic response of NF-jB
Tousled like kinase 1 (TLK1) TLK1 activity was inhibited in response to various DN
manner. CHK1 phosphorylated TLK1 on Ser695. A TLK1
and had a radio-protective effect, facilitating damage
CK 1d CK1d translocated to the nucleus and mediated p53 p
Lyn The src-like tyrosine kinase Lyn was activated in respo
and PKCd and modulated their activities, and also reg
Lymphocyte-speciﬁc
tyrosine kinase (LCK)
LCK’s activity was up-regulated in response to IR. The
associated with impaired DNA repair and chromosom
LIM domain kinase 2 Expression of the isoform LIMK2b is induced by IR in
early exit of the IR-induced G2/M arrestSer216 according to some labs, [98,99], or Ser191 according to an-
other lab, leading to its nuclear accumulation [100]. PLK3 also
phosphorylated CDC25A on Ser513 and Ser519. Substitutions of
these serine residues by alanines prevented IR-induced degrada-
tion of this phosphatase [101].
Aurora-A and Aurora-B, which regulate chromosome segrega-
tion and cytokinesis, are both inhibited by DNA damage to ensure
blocking of mitosis. In etoposide-treated cells, Aurora-A’s activity
was inhibited while the protein levels increased in a CHK1-depen-
dent manner [102]. Aurora-B activity was also inhibited in re-
sponse to IR, depending on protein phosphatase 1 (PP1) and
possibly PARP-1 [103,104]. PP1 is also involved in the regulation
of Aurora-A, since IR treatment of cells entering mitosis led to rapid
PP1-mediated dephosphorylation of Aurora-A on the activating
phosphorylation Thr288 [105,106]. Importantly, IR-induced activa-
tion of PP1 was mediated by an ATM phosphorylation of an inhib-
itory unit, I-2, which led to dissociation of the complex and
dephosphorylation of PP1 itself [103]. I-2 can also regulate Aur-
ora-A activity directly [106]. Thus, PP1 can act as an ATM effector
to control Aurora kinases as well as other kinases. Irrespective of
DNA damage, depletion of myosin-phosphatase targeting subunit
1 (MYPT1), a PP1 regulator, increased phosphorylation of PLK1 at
Thr210 [107,108]. PP1 also mediated an ATM-dependent inhibition
of activity of NIMA kinase 2 (NEK2) in response to IR [109,110]. The
NEK kinase family includes several kinases involved in cell cycle
regulation, and, apart from NEK2, other kinases in the NEK family
are also modulated by the DDR. Cells depleted of NEK1 failed to
activate cell cycle checkpoints in response to IR, and the activating
phosphorylation sites of CHK1 and CHK2 were impaired, resulting
in persistent DNA damage [111]. The activity of NEK1, which
translocated to the nucleus, did not depend on ATM or ATR, but
was required to maintain chromosomal stability and suppressReference
n kinase 1a (CK1a)-mediated phosphorylation [279]
by CHK1 or CHK2 [280]
int in response to DNA damage, and exhibited lower levels of [281]
rylated by CHK2 onThr288. TTK-depleted cells were impaired in [282,283]
osis by phosphorylation of p53 on Thr55 [284]
ated Myc expression, a process that is also controlled by MK2 is [285]
IR, in a wortmannin dependent manner. Activation of PAK2 by [286]
on of TrkA, a tyrosine kinase receptor involved in cell death. In
efﬁciency, possibly following elevation of the cellular amount of
[287,288]
ignaling, thereby rendering cells more resistant to etoposide
y effect on IKK and promoted an apoptotic signal
[289]
ng kinase NUAK1 was activated by LKB1 kinase. NUAK1 is
ting NUAK1 in the DDR
[290,291]
its activation loop in response to etoposide, in an ATM-
idant resveratrol blocks NF-jB activation in response to various
osphorylation, thereby modulating the interaction of PKD with
[292,293]
duced NF-jB response. Following DNA damage it translocated to
then retained in the nucleus in PML nuclear bodies, contributing
[294]
A damaging agents in an ATM-, NBS1- and CHK1-dependent
isoform lacking the N-terminus was translated in response to IR
repair, at least by phosphorylating RAD9
[295–300]
hosphorylation on Thr21 in response to doxorubicin [301]
nse to IR and associated with CDK1. Lyn interacted with DNA-PK
ulated the JNK pathway
[157,302,303]
oncogenic variant of LCK, with an F505Y mutation, was
al instability
[304–306]
a p-53 dependent manner. LIMK2b-depleted cells exhibited an [307]
A. Bensimon et al. / FEBS Letters 585 (2011) 1625–1639 1629lymphomagenesis [112,113]. NEK11 kinase activity was up-regu-
lated in response to etoposide, cisplatin and IR, and was activated
by a CHK1-mediated phosphorylation on Ser273 [114,115]. NEK11
phosphorylated CDC25A to regulate its degradation, and mutation
of the kinase at Ser273 to alanine or kinase-dead stabilized the pro-
tein level of CDC25A [115].
2.2. MAP kinases
The mammalian mitogen-activated protein kinases (MAPKs) are
a family of serine/threonine kinases with crucial roles in relaying
extracellular stimuli such as growth factors, cytokines, hormones
and various stresses into a variety of cellular processes affecting
cellular growth and proliferation, differentiation, and inﬂamma-
tion [116–118]. They are divided into three major groups: the
extracellular signal-regulated kinases (ERKs), the c-Jun N-terminal
kinases (JNKs, also known as the stress-activated protein kinase or
SAPK group), and the p38 MAPKs family. Each of these kinases ex-
ists in several isoforms and each MAPK signaling axis comprises at
least three kinase components: MAPK kinase kinases (MAP3Ks)
regulate MAPK kinase (MAP2Ks), which in turn regulate the MAPK
family as well as other kinases. The involvement of the MAPK fam-
ily in genotoxic responses has been reviewed [119,120], and here
we will mention the involvement of the he ERK, JNK and p38 ki-
nases, as well as upstream regulators.
ERK1/2 was activated, as measured by its state of phosphoryla-
tion, in response to etoposide, adriamycin and IR, in a manner
dependent on ATM and the upstream kinase MEK1, and was in-
volved in DNA damage-induced apoptosis [121]. The IR-induced
activation resulted in IR dose-dependent oscillations of ERK1/2
phosphorylation, which was dependent on EGFR and Src, and
was partially blocked by wortmannin [122]. As part of these oscil-
lations, the transient dephosphorylation of ERK1/2 was mediated
by an ATM-dependent regulation of the MAPK phosphatase 1
(MKP1) [123]. In turn, ERK1/2 facilitated etoposide/IR-induced
ATM activation, as indicated by p53 and CHK2 phosphorylation,
CDC25C phosphorylation, and G2/M cell cycle arrest [124,125].
Inhibition of ERK1/2 impaired IR-induced ATR, CHK1 and WEE1
activity, as well as ATM autophosphorylation and homologous
recombination repair (HRR) [125,126]. ERK1/2 was also involved
in regulating the stability of breast cancer type 1 susceptibility pro-
tein (BRCA1) after IR, while BRCA1 depletion impaired ERK phos-
phorylation after IR [127].
Two upstream MAPK kinases, MEK1 and MEK2, which can
phosphorylate ERK1/2, were activated by IR, and blockage of
MEK2 activation through the use of dominant negative kinase in-
creased sensitivity of the cell to IR and decreased the cellular
recovery from the G2/M cell cycle checkpoint arrest [128]. Possibly
related, in Xenopus egg extracts, ERK mediated phosphorylation of
CDC25 phosphatases, irrespective of DNA damage [129,130].
Downstream of MEK1, IR induced a transient increase of p90RSK
which was MEK1 and EGFR dependent [131]
p38 MAPK enzymatic activity was induced in response to vari-
ous DNA damaging agents [132]. Of note, UV irradiation activated
p38 more vigorously than IR, and activation induced by cisplatin
but not UV was c-Abl dependent [132,133]. UV-activated p38
phosphorylated CDC25B, modulating its interaction with 14-3-3
and facilitating the initiation of a G2/M checkpoint [134]. This oc-
curred in part through its ability to activate MAPK-activated pro-
tein (MAPKAP) kinase-2 (MK2). MK2, like CHK1 and CHK2,
phosphorylated CDC25B and CDC25C [135], and their involvement
in cell cycle regulation has been reviewed recently [79,136].
p38 and MK2 were activated in response to several DSB-induc-
ing agents as indicated by phosphorylation of MK2 on Thr334 and
phosphorylation of p38 on Thr180–Tyr182 [137]. Activation of
MK2 was ATR-dependent in response to doxorubicin, cisplatinand CPT, but ATM-dependent only in response to doxorubicin.
Importantly, depletion of MK2 in p53/ mouse embryonic ﬁbro-
blasts (MEFs) resulted in mitotic catastrophe after DNA damage
and diminished cell survival, since MK2 was required for the G2/
M checkpoint in these cells [137]. MK2 depletion impaired CDC25A
degradation in response to cisplatin, and CDC25B binding to 14-3-3
in response to doxorubicin [137,138]. Following DNA damage
induction, the p38/MK2 complex undergoes nuclear export, and
in the cytoplasm it is involved in maintenance of the G2/M check-
point via stabilization of speciﬁc mRNAs achieved by phosphoryla-
tion of players in this process [138]. MK2 in the DDR was also
demonstrated in the repression of Myc through an MK2-dependent
induction of miR-34c in response to etoposide, which led to S-
phase arrest [139]. Several kinases upstream of p38 MAPK were
implicated in the DDR. In response to IR, MAPK kinase 6 (MKK6)
was activated [140], as was MLK-related kinase (MRK, also known
as MLTK), which was autophosphorylated and contributed to phos-
phorylation of CHK2. It was required for cell cycle arrest, and for
IR-induced p38c activation but not p38a, [141,142]. Thousand
and one amino acid (TAO) kinases are MAP3Ks that activate p38
MAPK. TAOs were shown to be activated by IR and required for
p38 activation. IR activation of TAOs was abrogated in ATM-deﬁ-
cient cells, and TAO1 and TAO3 were shown to be phosphorylated
in response to IR [133]. Phosphorylation of TAO3 on Ser324 was
ATM-dependent and required for p38 MAPK activity [133]. Nota-
bly, evidenced by a ﬂuorescent reporter, MAP3Ks were activated
in the nucleus in response to etoposide, but not UV [143].
Relationships between ATM and p38 MAPK have been demon-
strated in relation to oxidative stress regulation, in addition to
ROS-driven activation of ATM [8–12]. The self-renewal capacity
of hematopoietic stem cells (HSCs) was found to depend on
ATM-mediated modulation of the response to oxidative stress
[144]. In Atm/ but not Atm+/+ mice, elevation of ROS levels led
to p38 activation and resulted in HSC exhaustion, which was
averted when p38 MAPK was inhibited, or upon treatment with
the antioxidant N-acetyl cysteine (NAC) [145]. Similarly, treatment
of Atm/ neuronal stem cells with NAC or with a p38 MAPK inhib-
itor improved their proliferation [146]. Treatment of Atm/ mice
with NAC reduced the acute sensitivity of these mice to IR, pre-
vented lymphomagenesis, and, interestingly, restored aberrant
DSB-repair dependent processes such as V(D)J recombination
[147]. One level at which these signals may converge is the mTOR
pathway discussed below, since both ATM and p38 MAPK/MK2 can
signal to tuberous sclerosis 2 protein (TSC2), which in turn
modulates mTOR signaling in response to ROS [16,148,149]. Inhibi-
tion or depletion of p38 MAPK also attenuated the doxorubicin-
induced response of the mTOR substrate p70 ribosomal S6 kinase
[150].
Another member of the MAPK family, c-Jun kinase (JNK), is acti-
vated by IR [151], in an ATM-dependent manner [152,153]. Timely
activation of JNK was regulated also by the MAPK kinase kinase
1(MEKK1), MKK7, c-Abl, DNA-PK, Lyn tyrosine kinase and protein
kinase Cd (PKCd) [154–157]. IR also promoted an interaction be-
tween JNK and the PI3K subunit p85a [151], and JNK promoted
c-Abl translocation into the nucleus in response to adriamycin,
by phosphorylation of 14-3-3, which retains c-Abl in the cytoplasm
[87]. Finally, JNK was recruited to H2AX phosphorylated on Tyr142,
possibly to induce pro-apoptotic functions, but substrates or rela-
tionships with other kinases recruited at the sites were not demon-
strated [158]. The MKK7–JNK pathway and the MKK3/6-p38-MAPK
pathway exhibit antagonistic roles in cell proliferation and senes-
cence [159,160]. The activation of JNK in response to doxorubicin
was dependent on 50-AMP-activated protein kinase (AMPK), and
was abolished in the presence of the antioxidant NAC, while in dro-
sophila, MKK7 and JNK mediated apoptotic cell death induced by
LKB1 [161,162]. According to tissue speciﬁc inactivation of MKK7
1630 A. Bensimon et al. / FEBS Letters 585 (2011) 1625–1639in a murine cancer model, MKK7 acted as a tumor suppressor by
affecting p53 stability, DDR signaling, and cell cycle arrest [163].
The mammalian sterile 20-like kinase 1 (MST1) is activated dur-
ing apoptosis and can promote apoptotic chromatin fragmentation
by activating JNK. JNK in turn phosphorylates MST1 to further pro-
mote its activation. In response to etoposide, MST1 activation was
required for apoptotic DNA fragmentation, accompanied by H2AX
phosphorylated on Ser139, which MST1 could phosphorylate
in vitro [164–166]. MST1 promoted apoptosis by translocating to
the nucleus, a process that was repressed by its Akt-mediated
phosphorylation [167]. In response to IR, MST1 activation coin-
cided with the activation of another downstream kinase, nuclear
Dbf2-related 1 (NDR1) kinase [168]. NDR1, which was associated
with lymphomagenesis, was involved in centrosome duplication
and the regulation of the G1/S cell cycle transition [168–170].
MST1 and NDR1 are involved in the correct alignment of mitotic
chromosomes through regulation of aurora B activity [171,172].
2.3. The Akt-mTOR-NF-kB connection
Akt (protein kinase B) is a kinase involved in cell cycle regula-
tion, cell survival and proliferation, and is activated downstream
of PI3K signaling [173]. In response to various stimuli, Akt is acti-
vated and this activation is associated with its phosphorylation
on Thr61 by 3-phosphoinositide-dependent protein kinase 1
(PDK1) and on Ser473, and may be followed by translocation to cel-
lular compartments [174,175]. Full activation of Akt, as measured
by the phosphorylation of Ser473, was ATM-dependent in response
to IR [176]. In contrast, Kwon et al. [177] reported that phosphor-
ylation of Akt, as well as Akt’s substrate glycogen synthase kinase
3b (GSK-3b), could be induced in response to IR to a similar extent
in ATM-deﬁcient and -proﬁcient cell lines. In murine Atm/ thy-
mocytes, the basal phosphorylation level of Akt was higher than
that in Atm+/+ thymocytes [178]. Ser473 of Akt can be phosphory-
lated by DNA-PK as well as mammalian target of rapamycin com-
plex 2 (mTORC2) in a signal context-dependent manner [179–183].
Inhibition of mTOR by rapamycin led to the activation of Akt in an
IGF1R-, PI3K-dependent manner [184,185]. Activation of Akt by
PDK1, and DNA-PK was critical for the correct regulation of p21
protein levels, and when mis-regulated, led to increased apoptosis
in response to IR [181].
Akt is involved in G2/M checkpoint and can phosphorylate
CHK1 on Ser280, which may be inhibitory since expression of acti-
vated Akt inhibited IR-induced CHK1 activity [186,187]. In re-
sponse to IR, Akt phosphorylated CLK2, a kinase involved in
alternative splicing regulation and cell cycle progression [188–
190]. Interestingly, CLK2 is the human homolog of the budding
yeast protein Tel2, involved in telomere length regulation, PIKK
stability, and localization of the ATM homolog TEL1 to DSBs
[191–193]. Inhibition of p38 MAPK or the upstream c-Src kinase
impaired the activation of Akt in response to IR [150,194], via an
unknown mechanism. A possible mechanism of this inhibition
may come from a study of the protection offered by the scatter fac-
tor (SF) against adriamycin-induced damage: intricate relations
were disclosed in this regard between numerous kinases, including
Src, Akt, MKK3/6 and p38 MAPK, TAK1 and NIK and the NFjB path-
way [195].
The mammalian target of rapamycin (mTOR; FRAP1), a member
of the PIKK family of protein kinases, is a cytoplasmic-nuclear
shuttling protein kinase that exists in two distinct multi-protein
complexes, TORC1 and TORC2. It regulates protein synthesis and
ribosome biogenesis as well as autophagy in response to various
stimuli and functions as a sensitive sensor of nutrient and redox
balances [196]. In murine Atm/ thymocytes, mTOR signaling
was mis-regulated as evidenced by phosphorylation of its sub-
strate eukaryotic initiation factor 4E (eIF4E)-binding protein(4EBP1); and inhibition of mTOR with rapamycin attenuated the
elevated phosphorylation and signiﬁcantly delayed thymic lym-
phoma development in Atm/ mice [16,178]. IR treatment was
shown to lead to ERK- and ATM-dependent transient increase in
cap-dependent mRNA translation that was associated with in-
creased phosphorylation of mTOR on Ser2448 [197]. Several hours
after IR, protein synthesis was inhibited in a p53-dependent man-
ner. Transient increase of p70 S6 kinase activity, an mTOR sub-
strate, was found in a breast carcinoma cell line and depended
on PI3K and EGFR [131]. However, the ﬁne-tuning and timing of
this damage response may be cell line- and damage type-depen-
dent, since mTOR activity in other cell lines was inhibited in a
p53- and AMPK-dependent manner, accompanied by a reduction
is p70 S6 kinase activity [198–200]. On the other hand, in response
to doxorubicin, p70 S6 kinase was activated in an mTOR – p38a-
dependent manner, and phosphorylated MDM2 on Ser163, which
inhibited MDM2 nuclear entry [150].
Putatively linked, mTOR was shown to be repressed in response
to an increase in ROS levels or IR, in a mechanism involving ATM-
dependent TSC2 activation via the LKB1/AMPK metabolic pathway
in the cytoplasm [16]. LKB1 was phosphorylated in response to IR
on Thr366 in an ATM-dependent manner, and although the function
of this phosphorylation event remains to be elucidated, mutation
of the site to alanine/glutamate moderately reduced the ability of
LKB1 to suppress cell growth [201,202]. LKB1 activated AMPK by
phosphorylating it on Thr172, which led to TSC2 phosphorylation
and down-regulation of mTOR [203,204]. There is evidence of the
involvement of this signaling mechanism in the DDR: AMPK phos-
phorylation was moderately induced in response to etoposide, in
an ATM-dependent manner, which promoted mitochondria bio-
genesis [15]; and LKB1 and AMPK were inducibly phosphorylated
on Ser428 and Thr172, respectively, in response to doxorubicin
[162]. AMPK was also activated in an ATM-dependent/LKB1-inde-
pendent manner in certain cell lines [205]. In B cells, DSBs induced
by etoposide or by activation-induced cytidine deaminase (AID)
activated ATM, which signaled through LKB1 to inactivate CRTC2,
which controls cell proliferation, self-renewal, and differentiation
– all involved in lymphomagenesis [206].
The core IjB kinase (IKK) complex, which activates the NF-jB
transcription factor family [207], consists of two catalytic subunits,
IKKa/IKK1 and IKKb/IKK2, and a regulatory subunit, IKKc/NEMO
(NF-kB essential modulator). Activated IKK phosphorylates IjB to
cause its ubiquitin-proteasome-mediated degradation, which in
turn releases NF-jB to the nucleus for transcriptional regulation.
The involvement of the NF-jB pathway in the cellular response
to genotoxic stresses, including DSBs, has been reviewed
[208,209], so we will focus on the roles of kinase cross-talks in this
context. In response to IR, ATM was demonstrated to be essential
for the activation of the NF-jB pathway, including IKK activation,
IjBa degradation, and induction of NF-jB DNA binding activity
[210].
In response to DNA damage, a small fraction of ATM associated
with IKKc/NEMO exited the nucleus and associated with IKK cata-
lytic subunits [211], a process in which PARP1 plays an important
role [212]. Importantly, activation of ATM by oxidative stress could
also lead to NFjB activation, while induction of DSBs per se by
restriction enzymes was insufﬁcient to lead to activation [213].
On the other hand, NF-jB response to AD288, a topoisomerase II
inhibitor that does not induce DSBs, was mediated by DNA-PK
and not ATM [214]. GSK-3b phosphorylation and activation in re-
sponse to IR contributed to an ATM-independent transcriptional
response of NF-jB, although the ATM-dependent pathway was
likely to be the more prominent one [177]. GSK-3b may explain
the observation that IR-induced activation of IKK in A-T lympho-
blasts was reduced and delayed but not abolished. ATR also inter-
acted with IKKc in response to replication stress: it did not seem to
A. Bensimon et al. / FEBS Letters 585 (2011) 1625–1639 1631phosphorylate it, and, rather, antagonized ATM-dependent NF-jB
activation [215]. TGFb-activated kinase (TAK1) was involved in
IKK activation in response to multiple stimuli; and, irrespective
of DNA damage, it was also able to phosphorylate MKK6, leading
to activation of the JNK pathway, which is also involved in the
DDR [216]. TAK1 was activated in response to etoposide, and was
required for activation of the IKK complex [217]. ATM regulated
the activation of TAK1 through the phosphorylation of IKKc, and
through the regulation of ELKS, which interacted with TAK1
[217]. In response to IR and doxorubicin but not etoposide, the
NF-jB response was modulated by the inhibition of MEK1, indicat-
ing this kinase may also be involved [218,219]. The NF-jB response
to doxorubicin may also involve p90RSK, since expression of a
dominant negative form delayed IjBa degradation [214]. Doxoru-
bicin-induced NF-jB response was also inhibited by the addition of
rapamycin, suggesting the involvement of an mTOR complex in IKK
activity like that previously shown irrespective of DNA damage
[220,221].
Cells depleted of another related kinase, receptor interacting
protein (RIP), were impaired in NF-jB signaling in response to
camptothecin (CPT), adriamycin and IR, but not UV [222]. Reconsti-
tution of these cells with WT or kinase-dead RIP restored a proper
NF-jB response after treatment with adriamycin [222], which also
led to the ATM-dependent formation of a complex between RIP
and IKKb. NF-jB-activating kinase (NIK) is known to be able to
activate the IKK complex in response to various stimuli, and
expression of a dominant-negative NIK inhibited NF-jB activation
in response to CPT [223].
The translocation of ATM in response to IR, as well as TAK1
phosphorylation were dependent on a steady state of calcium lev-
els, by an unknown mechanism [17]. The nuclear export of IKKc in
response to etoposide was also regulated by calcium levels [224].
One feasible explanation of how calcium regulates TAK1 is that cal-
cium-dependent signals are transduced to TAK1 through Ca2+/cal-
modulin-dependent protein kinases II (CaMKII), a kinase that
converts the calcium signal to a phosphorylation signal. Irrespec-
tive of DNA damage, TAK1 could be phosphorylated and activated
by CaMKII [225]. The activity of this kinase was stimulated upon IR
in an ATM-dependent manner, together with changes in calcium
concentration, and inhibition of CaMKII increased IR- or doxorubi-
cin-induced cell death [226–228]. CaMKII also phosphorylated
CDC25C, and thus played a role in the G2/M transition, but this
pathway has not been examined in the context of DSBs [229,230].
2.4. Tyrosine kinases and others
Several tyrosine kinases and dual-speciﬁcity kinases have been
implicated in the DDR, c-Abl and the EGF receptor (EGFR) being
prominent examples. Interestingly, tyrosine phosphorylation has
not been extensively investigated in the DDR context, implying
that novel DDR branches associated with tyrosine kinases remain
to be discovered.
c-Abl is a non-receptor tyrosine kinase that is ubiquitously ex-
pressed and localized in both the nucleus and cytoplasm. Its activ-
ity was up-regulated following exposure to DNA damage-inducers,
such as IR, cisplatin, and mitomycin C [231]. c-Abl interacted with
ATM and DNA-PK [232,233]. IR-induced activation of c-Abl re-
quired ATM, and it was assumed that ATM phosphorylates c-Abl
at Ser465, although such phosphorylation in cells was not directly
demonstrated [234]. IR led to an ATM-dependent disruption of a
complex between c-Abl and BRCA1, which may be a c-Abl target
[235]. In vitro, DNA-PK and c-Abl phosphorylated each other
[233]. In vivo, down-regulation of DNA-PK activity several hours
after IR was shown to be dependent on c-Abl [236]. c-Abl was tar-
geted from the cytoplasm to the nucleus in response to DNA dam-
age induced by adriamycin, and was liberated for translocation tothe nucleus by JNK-mediated phosphorylation of 14-3-3 [87]. The
cytoplasmic fraction of c-Abl was sequestered in the cytoplasm
by 14-3-3, which bound to c-Abl via c-Abl’s phosphorylation on
Thr735, which could be induced in cells by TTK in response to oxi-
dative damage [237]. Cells deﬁcient in c-Abl failed to induce a
MEKK1-dependent activation of JNK after IR [231], a process regu-
lated also by PKCd [157]. After IR, c-Abl phosphorylated MEKK1
and PKCd, and induced translocation of the latter to the nucleus
[154,238]. c-Abl also phosphorylated and activated hematopoietic
progenitor kinase (HPK1), which in turn mediated activation of JNK
by c-Abl [239].
c-Abl activated by IR was also shown to mediate phosphoryla-
tion of PI 3K and mTOR, leading to the inhibition these kinases’
activity [199,240]. In response to IR, EGFR translocated into the nu-
cleus and formed a complex with DNA-PK, facilitating DNA-PK’s
activation and autophosphorylation [241]. Inhibition of EGFR led
to reduced efﬁciency of the NHEJ route of DSB repair, while expres-
sion of a constitutively active variant of EGFR stimulated both the
HRR and NHEJ repair pathways [242,243]. Phosphorylation of EGFR
at several residues regulated the timely translocation and retention
of EGFR in the nucleus following DNA damage, and depended at
least in part on Src kinase [122,244,245]. Notably, Src itself was
also phosphorylated after IR treatment [122].
Downstream of EGFR are several PI3K/Akt- and Ras/Raf/MEK/
ERK-mediated signaling responses to IR (reviewed in [246]).
Importantly, these pathways could be activated by another recep-
tor involved in the response to IR, the insulin growth factor 1
receptor (IGF1R), which cross-talks with EGFR [247,248]. IGF1R
phosphorylation was up-regulated in response to IR, and fell to
baseline levels after several hours [249]. Down-regulation of IGF1R
led to cellular radiosensitivity, impaired p53 stabilization in re-
sponse to IR, and reduced basal levels of ATM [250]. A-T cells
had low levels of IGFIR, indicating a role for ATM in regulating
IGFIR expression, and their radiosensitivity was alleviated by IGF1R
expression [251]. The interaction of the IGF1R substrate with ATM
was up-regulated in response to cisplatin-induced DNA damage
[252,253]. Irrespective of DNA damage, IRS1 can also be phosphor-
ylated by p70S6K, leading to inhibition of IRS1, which provides a
feedback response from an mTOR substrate to the upstream IGF1R
signaling [254,255]. While each of these components was DNA
damage responsive, how DNA damage affects these cross-talks re-
mains to be elucidated.
Dual-speciﬁcity tyrosine-phosphorylation-regulated kinases
(DYRKs) are involved in regulation of cell survival or apoptosis in
response to DNA damage. DYRK2 was translocated to the nucleus
and mediated phosphorylation of p53 at Ser46, which potentiates
induction of apoptosis [256]. ATM was required for the damage-in-
duced nuclear translocation of DYRK2, and phosphorylated DYRK2
at Thr33 and Ser369. This phosphorylation protected DYRK2 from
MDM2-mediated degradation in the nucleus [257]. Interestingly,
DYRK2 also serves as a scaffold for the EDVP E3 ligase, in a complex
that includes DNA damage-binding protein 1 (DDB1), thus merging
recognition of a substrate, phosphorylation and degradation of at
least one substrate, Katanin p60 [258]. Since this complex was
shown to play a role in regulation of mitotic transition, and
DDB1 is a known DDR player which controls CHK1 stability
[259], perhaps future studies will show a role for this complex in
DDR. In contrast to DYRK2, DYRK1A and DYRK3 promoted cell sur-
vival by phosphorylation of SIRT1, which led to down-regulation of
DNA damage-induced acetylation of p53 [260]. How these kinases
are regulated in the DDR is unclear. However, DYRK1 was shown to
interact with two other kinases involved in the DDR, MEKK1 and
homodomain-interacting protein kinase 2 (HIPK2), via a scaffold
protein anthocyanin (Han11), and DYRK1 also interacted directly
with HIPK2 [261]. HIPK2 accumulated in response to IR, and could
interact with and phosphorylate p53 at Ser46, promoting apoptosis.
Table 2
Protein kinases identiﬁed as putative DDR players phosphoproteomic screens [(a) Matsuoka et al. [27], (b) Bennetzen et al. [62], (c) Bensimon et al. [61]] and functional screens
[(d) Paulsen et al. [308], (e) Lovejoy et al. [309], (f) O’Donnell et al. [310], (g) Hurov et al. [311], (h) O’Connell et al. [312]], and not mentioned in the text.
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but not CHK2 [262].
Finally, two additional protein kinases with an emerging role in
the DDR are CK2 andWSTF. Casein kinase 2 (CK2) represents a spe-
cial case as it is a constitutively active kinase. CK2 is involved in the
DDR from its early stages: CK2-mediated phosphorylation and
eviction from chromatin of HP 1b is a very early step in the DSB re-
sponse [263], and CK2 phosphorylation regulates the interaction of
two DSB sensors, Nijmegen breakage syndrome 1 (NBS1) and
mediator of DNA-damage checkpoint 1 (MDC1), at the DNA dam-
age sites [264,265]. CK2 also phosphorylates several DDR proteins
such as p53 and MDM2 [266]; not much is known, however, about
how CK2 itself is regulated in the DDR except that in response to IR,
CK2a0 translocates into the nucleus [267]. Williams–Beuren syn-
drome transcription factor (WSTF) interacted with H2AX and phos-
phorylated the histone at Tyr142, and depletion of WSTF abrogated
the maintenance of phosphorylation at Ser139 (which forms
cH2AX) and maintenance of MDC1/phospho-ATM foci [268].
Tyr142 was dephosphorylated by one of the phosphatases eyes ab-
sent homolog 1/3 (EYA1/EYA3) in response to IR, and at least EYA3
might be regulated by an ATM/ATR-mediated phosphorylation
[158]. Dephosphorylation promoted DSB repair rather than apop-
tosis [158]. The regulatory steps controlling WSTF kinase activity
in the DDR are still not known.2.5. Further additions to the protein kinase sub-network of the DDR
Several other kinases that have been linked to the DNA damage
response are presented in Table 1. For most of them, details of how
they are modulated by the DNA damage signal are largely missing.
Importantly, several phosphoproteomic and functional siRNA
screens performed in recent years in search of new DDR players
have turned up a number of additional protein kinases. These pro-
tein kinases, which are presented in Table 2, provide numerous
starting points for detailed studies of additional phosphorylation-
driven DDR pathways.3. Concluding remarks
At the systems level, the emerging picture of DNA damage-in-
duced protein phosphorylation (Fig. 1) still places ATM in a central
position, at least following the induction of DSBs. However, beyond
ATM lies a landscape of numerous other kinases, some of which
play critical roles in the DDR. One of the major functional princi-
ples governing the organization of the DDR is that it relies on a rel-
atively small core of DDR-dedicated proteins, but, once DNA
damage is induced, it rallies to the cause of cellular defense numer-
ous proteins that most of the time are involved in other processes
unrelated to DNA damage. In some cases these proteins acquire
functions in the DDR context different from the ones they exert
in ordinary times, and in other cases they continue their usual
tasks but operate them in DDR pathways. In the case of protein ki-
nases, it is safe to say they carry their kinase operations over to the
DDR, but their substrate speciﬁcity and/or subcellular localization
may change, often following their own damage-induced post-
translational modiﬁcations. Ample examples can be found in this
review. However, we cannot exclude the possibility that the action
of some of these kinases has minimal or no functional consequence
in the DDR.
Interesting and important players in the protein phosphoryla-
tion arena that were not discussed extensively here are protein
phosphatases. Notable examples documented in the DDR are PP5
[269,270], PP2A [271–273], WIP1 [274–276], and PP1 [103,277,
278]. The impact of dephosphorylation of a protein on its function
may be no less that its phosphorylation. Of note, our [61] andBennetzen et al.’s [62] phosphoproteomic screens identiﬁed a sub-
stantial number of protein dephosphorylations induced by DNA
damage. The cross-talk between kinases and phosphatases in the
DDR is an important area of research that is likely to shed light
on the still elusive process of DDR recovery.
Additional high-throughput proteomic and functional screens
related to other genotoxic stresses, and the elucidation of cross-
talks among the multitude of protein phosphorylation-driven
pathways in the DDR, are likely to substantiate the DDR as one
of the genome’s most extensive signaling networks that respond
to cellular stimuli.
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